Clinical Trials Browser

Phase 1 × NIH × Tolbutamide × Clear all

NCT01218620 2014-12-23

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Adult Solid Neoplasm